Ling Ma
Impact in
- Genetics top 5%
- Virus-based gene therapy research
- Molecular Biology top 10%
- CRISPR and Genetic Engineering
- RNA Interference and Gene Delivery
- Pluripotent Stem Cells Research
- Viral Infectious Diseases and Gene Expression in Insects
Papers in
-
- RNA Interference and Gene Delivery 7
- CRISPR and Genetic Engineering 5
- Pluripotent Stem Cells Research 5
- Genetics 13
- Virus-based gene therapy research 9
- Mesenchymal stem cell research 2
- Co-authors
- Thierry VandenDriessche (8 shared papers)Marinee Chuah (8 shared papers)Abel Acosta‐Sanchez (6 shared papers)Janka Mátrai (6 shared papers)Ermira Samara-Kuko (6 shared papers)Lajos Mátés (3 shared papers)Zoltán Ivics (3 shared papers)Zsuzsanna Izsvák (3 shared papers)
- Journals
- Stem Cell Research (3 papers)Current Cancer Drug Targets (3 papers)Human Gene Therapy (2 papers)Stem Cells (2 papers)Biomaterials (2 papers)
- Partner nations
- ChinaUnited StatesBelgium
In The Last Decade
Ling Ma
34 papers receiving 1.5k citations
Ling Ma's Hit Papers
Peers
Comparison fields: 5 of 94
- Genetics 628
- Molecular Biology 1.1k
- Biomaterials 166
- Oncology 269
- Genetics 97
Countries citing papers authored by Ling Ma
This map shows the geographic impact of Ling Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ma more than expected).
Fields of papers citing papers by Ling Ma
This network shows the impact of papers produced by Ling Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ma. The network helps show where Ling Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates Hit paper breakdown → | 2009 | 706 |
| 2 | 2006 | 163 | |
| 3 | 2011 | 111 | |
| 4 | 2006 | 106 | |
| 5 | 2005 | 88 | |
| 6 | 2014 | 83 | |
| 7 | 2013 | 39 | |
| 8 | 2010 | 39 | |
| 9 | 2019 | 29 | |
| 10 | 2016 | 19 | |
| 11 | Novel Hyperactive Transposons for Genetic Modification of Induced Pluripotent and Adult Stem Cells: A Non-Viral Paradigm for Coaxed Differentiation | 2010 | 17 |
| 12 | 2019 | 15 | |
| 13 | 2017 | 12 | |
| 14 | 2019 | 12 | |
| 15 | 2018 | 11 | |
| 16 | 2024 | 9 | |
| 17 | 2021 | 9 | |
| 18 | Characteristics of ovarian cancer cells transduced by the bicistronic retroviral vector containing GM-CSF and HSV-TK genes. | 2001 | 8 |
| 19 | 2006 | 7 | |
| 20 | 2008 | 7 |
About Ling Ma
Ling Ma is a scholar working on Molecular Biology, Genetics, Oncology, Genetics and Pathology and Forensic Medicine, having authored 34 papers that have together received 1.5k indexed citations. Recurring topics across this work include Virus-based gene therapy research (9 papers), RNA Interference and Gene Delivery (7 papers), CRISPR and Genetic Engineering (5 papers), Pluripotent Stem Cells Research (5 papers), Nanoparticle-Based Drug Delivery (3 papers), Cancer Mechanisms and Therapy (3 papers), Mesenchymal stem cell research (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Genetics (628 citations), Molecular Biology (1.1k citations), Biomaterials (166 citations), Oncology (269 citations) and Genetics (97 citations). Ling Ma has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Thierry VandenDriessche, Marinee Chuah, Abel Acosta‐Sanchez, Janka Mátrai, Ermira Samara-Kuko, Lajos Mátés, Zoltán Ivics, Zsuzsanna Izsvák, Eyayu Belay and Namitha Manoj. Their work appears in journals such as Stem Cell Research, Current Cancer Drug Targets, Human Gene Therapy, Stem Cells and Biomaterials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.